ChemInform Abstract: Preparation of 2‐Substituted Pyrroles and Indoles by Regioselective Alkylation and Deprotection of 1‐(2‐Trimethylsilylethoxymethyl)pyrrole and 1‐(2‐Trimethylsilylethoxymethyl)indole.

Martin P. Edwards(Pfizer (United States)), Helen M. Organ(Imperial College London), Steven V. Ley(University of Cambridge), Annette M. Doherty(Imperial College London)

Chemischer Informationsdienst

November 11, 1986

10.1002/chin.198645185

Cited by 0

Related Papers

Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)

|Journal of Medicinal Chemistry|2011|924

Targeting C-reactive protein for the treatment of cardiovascular disease

|Nature|2006|676

Discovery of (10 <i>R</i> )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- <i>2H</i> -8,4-(metheno)pyrazolo[4,3- <i>h</i> ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations

|Journal of Medicinal Chemistry|2014|587

Using the Golden Triangle to optimize clearance and oral absorption

|Bioorganic & Medicinal Chemistry Letters|2009|382

Lipophilic Efficiency as an Important Metric in Drug Design

|Journal of Medicinal Chemistry|2018|340